-

Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification

New automated kit overcomes major bottleneck in peptide production, providing optimized simultaneous workflows

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of its PurePep® EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.

Based on Gyros Protein Technologies’ orthogonal PurePep EasyClean technology, the PEC Auto Kit utilizes a simple catch-and-release methodology for purification of chemically synthesized peptides. The new Auto Kit allows users of the PurePep Chorus and Symphony® X synthesizer to perform peptide synthesis and purification on a single instrument, further increasing process efficiency.

Conventional chromatography, including reversed-phase liquid chromatography (RP-HPLC) is a major bottleneck in peptide production, both in academia and industry, due to its limited capacity in higher throughput purifications, and the significant volumes of toxic solvents required. In addition, operation of RP-HPLC is labour intensive and requires specialist skills. Gyros Protein Technologies’ PEC Auto Kit requires up to 90% less hands-on time per peptide (6 minutes vs ~ 1 hour) and 90% less solvent consumption, facilitating parallel purification of 6 or more purified peptides in under 6 hours.

Mark Vossenaar, General Manager, Biopharmaceutical Development Division, Gyros Protein Technologies, commented: “The PEC Auto Kit is the first automated solution for parallel peptide purification to remove a major bottleneck in the downstream production process, saving time and resources for this otherwise rate-limiting and labour-intensive step. The first newly developed product in the PurePep family following acquisition of the PEC technology in 2022, the introduction of the PEC Auto Kit further reflects our commitment to providing reliable and efficient solutions for the purification of high-quality peptides for research and production.”

Adrian Glas, CEO, Peptides Speciality Laboratories, said: “As a customer, the PurePep EasyClean technology has been an established method for purification in our labs from the very beginning. The introduction of the PEC Auto kit is the missing piece to a fully automated peptide manufacturing process. Now allowing for parallel post-synthesis purification, the new platform was easily integrated into our laboratory methods and has provided immediate benefits. The automation has taken it to the next level in terms of time efficiency and resource reduction!”

For more information on the PurePep® EasyClean Auto Kit, please visit: www.gyrosproteintechnologies.com/peptides/products/purepep-easyclean-auto-kit

Contacts

Dr Ben Rutter
Tel: +44 (0) 7920 770 935
Email: ben.rutter@zymecommunications.com

Gyros Protein Technologies


Release Versions

Contacts

Dr Ben Rutter
Tel: +44 (0) 7920 770 935
Email: ben.rutter@zymecommunications.com

More News From Gyros Protein Technologies

Gyros Protein Technologies Introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to Support Biotherapeutic Development

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents. Developed with antibodies from BioGenes GmbH, a global leader in host cell protein (HCP) assay development, the new kits enable rapid detection of HCPs from HEK293 cell lines, adding to Gyros Protein Technologi...

Gyros Protein Technologies Introduces Gyrolab Generic Anti-AAV Kit to Support Gene Therapy Development

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers today announced the introduction of its Gyrolab® Generic Anti-Adeno Associated Virus (AAV) Kit. The new ready-to-use kit facilitates the qualitative assessment of pre-existing binding antibodies against AAV vectors, enabling screening in pre-clinical and clinical settings. The kit supports identification of pre-existing immunity that m...

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG. Validated for use with mouse and rat samples, the Kit Reagents provide a ready-to-use solution to accelerate screening of biotherape...
Back to Newsroom